サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1631227

心臓バイオマーカー診断検査キットの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Cardiac Biomarker Diagnostic Test Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 209 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
心臓バイオマーカー診断検査キットの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月03日
発行: Fairfield Market Research
ページ情報: 英文 209 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓バイオマーカー診断検査キット市場は、心血管疾患に対する意識の高まりと診断技術の進歩に牽引され、大きな成長が見込まれています。これらのキットは、心臓関連疾患の早期発見と管理に不可欠であり、タイムリーな介入を可能にし、患者の転帰を改善します。心臓バイオマーカー診断検査キットの市場規模は、2023年から2032年にかけて安定したCAGR 5.70％で成長し、2025年には18億9,000万米ドル、2032年には27億9,000万米ドルに達すると予測されています。

これらの診断ソリューションの需要は、生活習慣に関連する健康リスクと世界人口の高齢化の組み合わせによって推進され、心血管の健康課題に対処するための革新的なツールの緊急ニーズを生み出しています。心臓バイオマーカー診断検査キット市場は、革新的で正確かつタイムリーな診断ツールに対する需要が高まるにつれて、力強い成長を示すことになるとみられています。POC検査、AI統合、新興市場での機会拡大により、この分野は心血管治療を変革し、世界の健康アウトカムを改善する軌道に乗っています。

心筋梗塞や心不全のような心血管疾患の罹患率の上昇は、市場成長の主な促進要因です。心臓バイオマーカー検査キットは早期発見を可能にし、これらの重要な疾患の効果的な管理を保証します。高感度アッセイとマルチプレックスイムノアッセイの革新により、心臓バイオマーカー検査の精度と効率が向上し、医療従事者の間で採用が進んでいます。早期発見の重要性に対するヘルスケア専門家や患者の意識の高まりが、心臓バイオマーカー診断検査キットの需要拡大につながっています。

当レポートでは、世界の心臓バイオマーカー診断検査キット市場について調査し、市場の概要とともに、製品タイプ別、適応症別、最終用途別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の心臓バイオマーカー診断検査キット市場の見通し、2019年～2032年

  • 世界の心臓バイオマーカー診断検査キット市場の見通し、製品タイプ別、金額（10億米ドル）、2019年～2032年
  • 世界の心臓バイオマーカー診断検査キット市場の見通し、適応症別、金額（10億米ドル）、2019年～2032年
  • 世界の心臓バイオマーカー診断検査キット市場の見通し、最終用途別、金額（10億米ドル）、2019年～2032年
  • 世界の心臓バイオマーカー診断検査キット市場の見通し、地域別、金額（10億米ドル）、2019年～2032年

第4章 北米の心臓バイオマーカー診断検査キット市場の見通し、2019年～2032年

第5章 欧州の心臓バイオマーカー診断検査キット市場の見通し、2019年～2032年

第6章 アジア太平洋の心臓バイオマーカー診断検査キット市場の見通し、2019年～2032年

第7章 ラテンアメリカの心臓バイオマーカー診断検査キット市場の見通し、2019年～2032年

第8章 中東・アフリカの心臓バイオマーカー診断検査キット市場の見通し、2019年～2032年

第9章 競合情勢

  • 最終用途別vs適応症別ヒートマップ
  • メーカー別vs適応症別ヒートマップ
  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Danaher Corporation
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd.
    • Siemens AG
    • BioMerieux SA
    • Randox Laboratories Ltd.
    • その他

第10章 付録

目次

The cardiac biomarker diagnostic test kits market is poised for significant growth, driven by increasing awareness of cardiovascular diseases and advancements in diagnostic technologies. These kits are essential for early detection and management of heart-related conditions, enabling timely intervention and improving patient outcomes. The cardiac biomarker diagnostic test kits market is projected to grow at a steady CAGR of 5.70% between 2023 and 2032, reaching an estimated valuation of USD 1.89 billion by 2025 and USD 2.79 billion by 2032.

Market Insights

The demand for these diagnostic solutions is propelled by a combination of lifestyle-related health risks and an aging global population, creating an urgent need for innovative tools to address cardiovascular health challenges. The cardiac biomarker diagnostic test kits market is set to witness robust growth as demand for innovative, accurate, and timely diagnostic tools rises. With expanding opportunities in POC testing, AI integration, and emerging markets, the sector is on a trajectory to transform cardiovascular care and improve global health outcomes.

Market Drivers

  • 1. Rising Cardiovascular Disease Prevalence: The growing incidence of cardiovascular conditions like myocardial infarction and heart failure is a major driver of market growth. Cardiac biomarker test kits enable early detection, ensuring effective management of these critical conditions.
  • 2. Technological Advancements: Innovations in high-sensitivity assays and multiplex immunoassays have enhanced the precision and efficiency of cardiac biomarker testing, fostering increased adoption among healthcare providers.
  • 3. Increased Healthcare Awareness: Growing awareness among healthcare professionals and patients about the importance of early detection has led to greater demand for cardiac biomarker diagnostic test kits.

Business Opportunities

  • 1. Point-of-Care (POC) Testing: Expanding POC testing capabilities presents a significant opportunity for manufacturers. Rapid and user-friendly POC test kits allow for immediate, on-site diagnosis, catering to emergency and remote healthcare settings.
  • 2. AI Integration: Incorporating artificial intelligence (AI) into diagnostic solutions can enhance accuracy by analyzing complex biomarker patterns and providing predictive insights. This integration positions companies at the forefront of innovation in cardiac diagnostics.
  • 3. Emerging Markets: Growing healthcare investments and rising cardiovascular disease prevalence in regions such as South Asia and the Pacific offer untapped opportunities for market expansion.

Regional Analysis

  • Europe: Europe leads the global market due to its advanced healthcare infrastructure and emphasis on preventive care. The region's focus on research and adherence to clinical standards further solidifies its dominance.
  • South Asia and Pacific: This region is the fastest-growing market segment, driven by an increased burden of cardiovascular diseases and significant investments in healthcare infrastructure.
  • North America: North America remains a key market due to high awareness levels and the availability of advanced diagnostic technologies.

Key Players Leading companies in the cardiac biomarker diagnostic test kits market include:

  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • BioMerieux SA
  • Randox Laboratories Ltd.

These organizations continue to drive innovation and expand their market presence through strategic collaborations, product launches, and technological advancements.

Market Segmentation The market is segmented as follows:

  • By Product Type: Brain Natriuretic Peptide (BNPs) Test Kits Creatine Kinase MB (CK-MB) Test Kits Troponin (I&T) Test Kits Myoglobin Test Kits Others
  • By Indication: Angina Pectoris Acute Myocardial Infarction Congestive Heart Failure Others
  • By End-Use: Hospitals Diagnostic Laboratories Outpatient Clinics Academic & Research Institutes
  • By Region: North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cardiac Biomarker Diagnostic Test Kits Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 3.1. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 3.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 3.1.1.3. Troponin (I&T) Test Kit
      • 3.1.1.4. Myoglobin Test Kit
      • 3.1.1.5. Others
  • 3.2. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Angina Pectoris
      • 3.2.1.2. Acute Myocardial Infarction
      • 3.2.1.3. Congestive Heart Failure
      • 3.2.1.4. Others
  • 3.3. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Diagnostic Laboratories
      • 3.3.1.3. Outpatient Clinics
      • 3.3.1.4. Academic & Research Institutes
  • 3.4. Global Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 4.1. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 4.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 4.1.1.3. Troponin (I&T) Test Kit
      • 4.1.1.4. Myoglobin Test Kit
      • 4.1.1.5. Others
  • 4.2. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Angina Pectoris
      • 4.2.1.2. Acute Myocardial Infarction
      • 4.2.1.3. Congestive Heart Failure
      • 4.2.1.4. Others
  • 4.3. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Diagnostic Laboratories
      • 4.3.1.3. Outpatient Clinics
      • 4.3.1.4. Academic & Research Institutes
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. U.S. Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. U.S. Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 5.1. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 5.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 5.1.1.3. Troponin (I&T) Test Kit
      • 5.1.1.4. Myoglobin Test Kit
      • 5.1.1.5. Others
  • 5.2. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Angina Pectoris
      • 5.2.1.2. Acute Myocardial Infarction
      • 5.2.1.3. Congestive Heart Failure
      • 5.2.1.4. Others
  • 5.3. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Diagnostic Laboratories
      • 5.3.1.3. Outpatient Clinics
      • 5.3.1.4. Academic & Research Institutes
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 6.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 6.1.1.3. Troponin (I&T) Test Kit
      • 6.1.1.4. Myoglobin Test Kit
      • 6.1.1.5. Others
  • 6.2. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Angina Pectoris
      • 6.2.1.2. Acute Myocardial Infarction
      • 6.2.1.3. Congestive Heart Failure
      • 6.2.1.4. Others
  • 6.3. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Diagnostic Laboratories
      • 6.3.1.3. Outpatient Clinics
      • 6.3.1.4. Academic & Research Institutes
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 7.1. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 7.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 7.1.1.3. Troponin (I&T) Test Kit
      • 7.1.1.4. Myoglobin Test Kit
      • 7.1.1.5. Others
  • 7.2. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
      • 7.2.1.1. Angina Pectoris
      • 7.2.1.2. Acute Myocardial Infarction
      • 7.2.1.3. Congestive Heart Failure
      • 7.2.1.4. Others
  • 7.3. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Diagnostic Laboratories
      • 7.3.1.3. Outpatient Clinics
      • 7.3.1.4. Academic & Research Institutes
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Brain Natriuretic Peptide (BNPs) Test Kit
      • 8.1.1.2. Creatine Kinase MB (CK-MB) Test Kit
      • 8.1.1.3. Troponin (I&T) Test Kit
      • 8.1.1.4. Myoglobin Test Kit
      • 8.1.1.5. Others
  • 8.2. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Indication, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Angina Pectoris
      • 8.2.1.2. Acute Myocardial Infarction
      • 8.2.1.3. Congestive Heart Failure
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by End Use, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Diagnostic Laboratories
      • 8.3.1.3. Outpatient Clinics
      • 8.3.1.4. Academic & Research Institutes
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by Product Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by Indication, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Cardiac Biomarker Diagnostic Test Kits Market by End Use, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By End Use vs by Indication Heat map
  • 9.2. Manufacturer vs by Indication Heatmap
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Abbott Laboratories
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Danaher Corporation
    • 9.5.3. Bio-Rad Laboratories
    • 9.5.4. Thermo Fisher Scientific, Inc.
    • 9.5.5. Becton, Dickinson and Company
    • 9.5.6. F. Hoffmann-La Roche Ltd.
    • 9.5.7. Siemens AG
    • 9.5.8. BioMerieux SA
    • 9.5.9. Randox Laboratories Ltd.
    • 9.5.10. Others

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations